Donald Kennedy On Fund Raising, Federal Aid and Scientific Fraud

Donald Kennedy’s career as biologist, educator and administrator reflects his belief that scientists and other academics should speak out on public policy issues and conskier devoting some time to public service. As a result, his views on science, education, federal regulation and related topics have received wide circulation, whether he was speaking as a White House consultant, U.S. Food and Drug Administration commissioner or in his current position as president of Stanford University.

Written byTabitha M. Powledge
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Donald Kennedy’s career as biologist, educator and administrator reflects his belief that scientists and other academics should speak out on public policy issues and conskier devoting some time to public service. As a result, his views on science, education, federal regulation and related topics have received wide circulation, whether he was speaking as a White House consultant, U.S. Food and Drug Administration commissioner or in his current position as president of Stanford University.

Kennedy was born in New York City and educated at Harvard University receiving a Ph.D. in neurophysiology in 1956. After a stint as a biology teacher and researcher at Syracuse University he moved to Stanford as an assistant professor of biology in 1960, and live years later was named chairman of its Biological Sciences Department. His interest in policy issues relating to food, nutrition and life sciences led to his appointment as a consultant to the White ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies